NCI Says Long-Awaited Long Island Breast Cancer Study Now Underway

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 8
Volume 5
Issue 8

BETHESDA, Md--The Long Island Breast Cancer Study Project, ordered by Congress in 1993, is now underway under the auspices of the NCI and the National Institute of Environmental Health Sciences. The study will attempt to determine whether pollutants (pesticides and other chemical irritants) are linked to the area's excessive breast cancer rates.

BETHESDA, Md--The Long Island Breast Cancer Study Project, orderedby Congress in 1993, is now underway under the auspices of theNCI and the National Institute of Environmental Health Sciences.The study will attempt to determine whether pollutants (pesticidesand other chemical irritants) are linked to the area's excessivebreast cancer rates.

During, the 4-year study, being conducted by researchers fromColumbia University School of Public Health, 33 Long Island hospitalswill provide the names of newly diagnosed breast cancer patientswhom the researchers will invite to join the study. Blood andurine samples will be taken prior to treatment, along with a familyand medical history. The researchers will collect dust, water,and soil samples from the homes of 325 participants. Planned enrollmentis 1,600 patients plus 1,600 controls, with results expected by1999.

Recent Videos
Leading experts in the breast cancer field highlight the use of CDK4/6 inhibitors, antibody-drug conjugates, and other treatment modalities.
Patients with node-negative disease who are older and have comorbidities may not be suitable to receive CDK4/6 inhibitors.
An observed carryover effect with CDK4/6 inhibitors may reduce the risk of recurrence years after a patient stops treatment.
Breast oncologist Jade E. Jones, MD, says she tries to send patients with BRCA-mutant HR-positive TNBC to clinical trials that use PARP inhibitors.